Cooperating oncogenes converge to regulate cyclin/cdk complexes

Genes and Development

Volumn 11, Issue 5, 1997, Pages 663-677

  Lloyd, Alison C ^a   Obermüller, Frank ^a   Staddon, Susan ^a   Barth, Carolyn F ^a   McMahon, Martin ^b   Land, Hartmut ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cell cycle; cyclin dependent kinase; oncogenes; p21(Cip1); p53; Raf

Indexed keywords

CYCLINE;

ARTICLE; CANCER; CANCER RESEARCH; CELL CYCLE; CELL PROLIFERATION; ENZYME ACTIVATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SCHWANN CELL;

EID: 0030950537     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.5.663     Document Type: Article

References (73)

1. Ballester, R., D. Marchuk, M. Boguski, A. Saulino, R. Letcher, M. Wigler, and F. Collins. 1990. The NFl locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63: 851-859.
2. Basu, T.N., D.H. Gutmann, J.A. Fletcher, T.W. Glover, F.S. Collins, and J. Downward. 1992. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713-715.
3. Bates, S., D. Parry, L. Bonetta, K. Vousden, C. Dickson, and G. Peters. 1994. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9: 1633-1640.
4. Brockes, J.P., K.L. Fields, and M.C. Raff. 1979. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res. 165: 105-118.
5. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
6. DeClue, J.E., A.G. Papageorge, J.A. Fletcher, S.R. Diehl, N. Ratner, W.C. Vass, and D.R. Lowy. 1992. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69: 265-273.
7. Cip1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
8. Dulic, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, E. Lees, J.W. Harper, S.J. Elledge, and S.I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023.
9. el-Deiry, W., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
10. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499-502.
11. Fanidi, A., E.A. Harrington, and G.I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556.
12. Finlay, C.A., P.W. Hinds, T.H. Tan, D. Eliyahu, M. Oren, and A.J. Levine. 1988. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell. Biol. 8: 531-539.
13. Girard, F., U. Strausfeld, A. Fernandez, and N.J. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169-1179.
14. Gonos, E.S., J.S. Burna, G.R. Mazars, A. Kobrna, T.E. Riley, S.C. Barnett, G. Zafarana, R.L. Ludwig, Z. Ikram, A.J. Powell, and P.S. Jat. 1996. Rat embryo fibroblasts immortalised with simian virus large T antigen undergo senescence upon its inactivation. Mol Cell. Biol. 16: 5127-5138.
15. Gu, Y., J. Rosenblatt, and D.O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11: 3995-4005.
16. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
17. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
18. Harper, J.W., S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, C.L. Connell, E. Swindell, et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol Biol. Cell 6: 387-400.
19. Harvey, D.W. and A.J. Levine. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes & Dev. 5: 2375-2385.
20. Hunter, T. 1991. Cooperation between oncogenes. Cell 64: 249-270.
21. Jat, P.S., C.L. Cepko, R.C. Mulligan, and P.A. Sharp. 1986. Recombinant retroviruses encoding simian virus 40 large T antigen and polyomavirus large and middle T antigens. Mol. Cell. Biol. 6: 1204-1217.
22. Jiang, H., J. Lin, Z.Z. Su, F.R. Collart, E. Huberman, and P.B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406.
23. Kastan, M.B., Q. Zhan, W.S. el-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597.
24. Kern, S.E., J.A. Pietenpol, S. Thiagalingam, A. Seymour, K.W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827-830.
25. Kim, H.A., T. Rosenbaum, M.A. Marchionni, N. Ratner, and J.E. DeClue. 1995. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene 11: 325-335.
26. Kuerbitz, S.J., B.S. Plunkett, V.W. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl Acad. Sci. 89: 7491-7495.
27. Lane, D.P. and L.V. Crawford. 1980. The complex between simian virus 40 T antigen and a specific host protein. Proc. R. Soc. Lond. B. Biol. Sci. 210: 451-463.
28. Leevers, S.J. and C.J. Marshall. 1992. Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBO J. 11: 569-574.
29. Li, Y., C.W. Jenkins, M.A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9: 2261-2268.
30. Liu, J.J., J.R. Chao, M.C. Jiang, S.Y. Ng, J.J. Yen, and Y.H. Yang. 1995. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15: 3654-3663.
31. WAF1-CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56: 31-35.
32. Lukas, J., H. Muller, J. Bartkova, D. Spitkovsky, A.A. Kjerulff, D.P. Jansen, M. Strauss, and J. Bartek. 1994. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125: 625-638.
33. Macleod, K.F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes &. Dev. 9: 935-944.
34. Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380: 262-265.
35. Maltzman, W., M. Oren, and A.J. Levine. 1981. The structural relationships between 54,000-molecular-weight cellular tumor antigens detected in viral- and nonviral-transformed cells. Virology 112: 145-156.
36. Markowitz, D., C. Hesdorffer, M. Ward, S. Goff, and A. Bank. 1990. Retroviral gene transfer using safe and efficient packaging cell lines. Ann. N.Y. Acad. Sci. 612: 407-414.
37. Martin, G.A., D. Viskochil, G. Bollag, P.C. McCabe, W.J. Crosier, H. Haubruck, L. Conroy, R. Clark, P. O'Connell, R.M. Cawthon, et al. 1990. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63: 843-849.
38. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14: 2066-2076.
39. Mazarakis, N.D., N. Yannoutsos, J.N. El-Jabbour, W. Hatton, R. Fletcher, and F. Grosveld. 1996. Neurocristopathy resembling neurofibromatosis type 1 in an NGF-SV40 transgenic line. Genes Cells 1: 125-137.
40. Menon, A.G., K.A. Anderson, V.M. Riccardi, R.Y. Chung, J.M. Whaley, D.W. Yandell, G.E. Farmer, R.N. Freiman, J.K. Lee, F.P. Li, et al. 1990. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc. Natl. Acad. Sci. 87: 5435-5439.
41. Michieli, P., M. Chedid, D. Lin, J.H. Pierce, W.E. Mercer, and D. Givol. 1994. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54: 3391-3395.
42. Miller, A.D. and G.J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7: 980-982.
43. Moodie, S.A., B.M. Willumsen, M.J. Weber, and A. Wolfman. 1993. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. Science 260: 1658-1661.
44. Morgenstern, J.P. and H. Land. 1990. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary elper-free packaging cell line. Nucleic Acids Res. 18: 3587-3596.
45. Noda, A., Y. Ning, S.F. Venable, S.O. Pereira, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
46. Ohtsubo, M., A.M. Theodoras, J. Schumacher, J.M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15: 2612-2624.
47. Oshima, J., K.E. Steinmann, J. Campisi, and R. Schlegel. 1993. Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen. Oncogene 8: 2987-2993.
48. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11: 961-971.
49. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes & Dev. 8: 9-22.
50. Raff, M.C., R.H. Miller, and M. Noble. 1983. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature 303: 390-396.
51. Ridley, A.J., H.F. Paterson, M. Noble, and H. Land. 1988. Rasmediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. EMBO J. 7: 1635-1645.
52. Rudolph, B., R. Saffrich, J. Zwicker, B. Henglein, R. Muller, W. Ansorge, and M. Eilers. 1996. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A, but not apoptosis. EMBO J. 15: 3065-3076.
53. Samuels, M.L., M.J. Weber, J.M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol. Cell. Biol. 13: 6241-6252.
54. Serrano, M.L., L.E. Gomez, R.A. DePinho, D. Beach, and S.D. Bar. 1995. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267: 249-252.
55. Serrano, M., H.-W. Lee, L. Chin, C. Cordon-Cardo, D. Beach, and R.A. DePinho. 1996. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37.
56. Slingerland, J.M., L. Hengst, C.H. Pan, D. Alexander, M.R. Stampfer, and S.I. Reed. 1994. A novel inhibitor of cyclinCdk activity detected in transforming growth factor betaarrested epithelial cells. Mol Cell. Biol. 14: 3683-3694.
57. Steinman, R.A., B. Hoffman, A. Iro, C. Guillouf, D.A. Liebermann, and M.E. el-Houseini. 1994. Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396.
58. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74.
59. Tsai, L.H., E. Lees, B. Faha, E. Harlow, and K. Riabowol. 1993. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8: 1593-1602.
60. Van Aelst, L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 1993. Complex formation between RAS and RAF and other protein kinases. Proc. Natl. Acad. Sci. 90: 6213-6217.
61. van den Heuvel, S. and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
62. Kip1 is abrogated by c-Myc. EMBO J. 15: 6595-6604.
63. Vojtek, A.B., S.M. Hollenberg, and J.A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214.
64. Vojtesek, B., J. Bartek, C.A. Midgley, and D.P. Lane. 1992. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. Immunol. Methods 151: 237-244.
65. Waldman, T., K.W. Kinzler, and B. Vogelstein. 1995. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55: 5187-5190.
66. Warne, P.H., P.R. Viciana, and J. Downward. 1993. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 364: 352-355.
67. Winston, J.T., S.R. Coats, Y.Z. Wang, and W.J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12: 127-134.
68. Wood, K.W., H. Qi, G. D'Arcangelo, R.C. Armstrong, T.M. Roberts, and S. Halegoua. 1993. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: A potential role for cellular raf kinases in neuronal growth factor signal transduction. Proc. Natl. Acad. Sci. 90: 5016-5020.
69. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
70. Xu, G.F., B. Lin, K. Tanaka, D. Dunn, D. Wood, R. Gesteland, R. White, R. Weiss, and F. Tamanoi. 199Oa. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63: 835-841.
71. Xu, G.F., P. O'Connell, D. Viskochil, R. Cawthon, M. Robertson, M. Culver, D. Dunn, J. Stevens, R. Gesteland, R. White, and et al. 1990b. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62: 599-608.
72. Zhang, H., G.J. Hannon, and D. Beach. 1994. p21 -containing cyclin kinases exist in both active and inactive states. Genes & Dev. 8: 1750-1758.
73. Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, J. Wang, D. Fesquet, B. Henglein, and C. Brechot. 1992. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182: 1144-1154.